Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chromocell Therapeutics Corp.

1.45
+0.09947.36%
Volume:6.57K
Turnover:9.40K
Market Cap:8.85M
PE:-1.01
High:1.57
Open:1.33
Low:1.33
Close:1.35
Loading ...

Company Profile

Company Name:
Chromocell Therapeutics Corp.
Exchange:
AMEX
Establishment Date:
2002
Employees:
- -
Office Location:
4400 Route 9 South,Suite 1000,Freehold,New Jersey,United States
Zip Code:
07728
Fax:
- -
Introduction:
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.

Directors

Name
Position
Chia Lin Simmons
Director
Ezra Friedberg
Director
Richard Malamut
Director
Todd Davis
Director

Shareholders

Name
Position
Francis Knuettel II
Interim Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary
Eric Lang
Chief Medical Officer